Literature DB >> 24436525

Lung cancer staging: clinical and radiologic perspectives.

Sophie Chheang1, Kathleen Brown2.   

Abstract

Published in 2009, the 7th edition of the American Joint Committee on Cancer TNM staging system is the culmination of an extensive worldwide initiative to standardize and validate lung cancer staging. Unlike prior editions, the new staging system is now inclusive of small cell carcinoma and carcinoid tumors. In addition, significant changes were made to the T and M descriptors, resulting in improved prognostic stratification of disease. This review article highlights these changes, the rationale for their inclusion in the new staging manual, and the role of the radiologist in determining stage.

Entities:  

Keywords:  TNM classification; imaging; lung cancer; staging

Year:  2013        PMID: 24436525      PMCID: PMC3709937          DOI: 10.1055/s-0033-1342950

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  63 in total

1.  Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1 cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions.

Authors:  N C Gupta; G M Graeber; H A Bishop
Journal:  Chest       Date:  2000-03       Impact factor: 9.410

2.  Malignant chest wall neoplasms of bone and cartilage: a pictorial review of CT and MR findings.

Authors:  P O'Sullivan; H O'Dwyer; J Flint; P L Munk; N L Muller
Journal:  Br J Radiol       Date:  2006-06-22       Impact factor: 3.039

3.  Should the 7th edition of the lung cancer stage classification system change treatment algorithms in non-small cell lung cancer?

Authors:  Daniel J Boffa; Frank C Detterbeck; Erica J Smith; Ramon Rami-Porta; John Crowley; Daniel Zelterman; Lynn Tanoue; Anthony W Kim; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2010-11       Impact factor: 15.609

4.  The new taxonomy of lung adenocarcinoma stemming from a multidisciplinary integrated approach: novel pathology concepts and perspectives.

Authors:  Giuseppe Pelosi
Journal:  J Thorac Oncol       Date:  2011-02       Impact factor: 15.609

5.  Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.

Authors:  Ping Yang; Mark S Allen; Marie C Aubry; Jason A Wampfler; Randolph S Marks; Eric S Edell; Stephen Thibodeau; Alex A Adjei; James Jett; Claude Deschamps
Journal:  Chest       Date:  2005-07       Impact factor: 9.410

6.  A system for the clinical staging of lung cancer.

Authors:  C F Mountain; D T Carr; W A Anderson
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-01

Review 7.  Radiologic implications of the 2011 classification of adenocarcinoma of the lung.

Authors:  John H M Austin; Kavita Garg; Denise Aberle; David Yankelevitz; Keiko Kuriyama; Hyun-Ju Lee; Elisabeth Brambilla; William D Travis
Journal:  Radiology       Date:  2012-10-15       Impact factor: 11.105

8.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

9.  Quality of life of long-term survivors of non-small-cell lung cancer.

Authors:  Linda Sarna; Geraldine Padilla; Carmack Holmes; Donald Tashkin; Mary Lynn Brecht; Lorraine Evangelista
Journal:  J Clin Oncol       Date:  2002-07-01       Impact factor: 44.544

Review 10.  Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.

Authors:  A Parsons; A Daley; R Begh; P Aveyard
Journal:  BMJ       Date:  2010-01-21
View more
  25 in total

1.  Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer.

Authors:  Cuixia Cai; Rong Shi; Yuan Gao; Jun Zeng; Min Wei; Handuo Wang; Wenling Zheng; Wenli Ma
Journal:  Oncol Lett       Date:  2015-09-23       Impact factor: 2.967

2.  Clinical significance of serum and tumor tissue endostatin evaluation in operable non-small cell lung cancer.

Authors:  Ming-Ming Hu; Ying Hu; Hai-Qing Zhang; Wen-Yun Jia; Zhe Qian; Yuan Yang; Bao-Lan Li
Journal:  Biomed Rep       Date:  2014-07-25

3.  Long noncoding RNA CASC15 predicts unfavorable prognosis and exerts oncogenic functions in non-small cell lung cancer.

Authors:  Min Li; Yu Chen; Jicun Zhu; Zhan Gao; Tao Wang; Pengli Zhou
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

4.  Long noncoding RNA NBAT1 inhibits autophagy via suppression of ATG7 in non-small cell lung cancer.

Authors:  Tianliang Zheng; Deping Li; Zhanfeng He; Shuaibing Feng; Song Zhao
Journal:  Am J Cancer Res       Date:  2018-09-01       Impact factor: 6.166

5.  Identification of LINC00665-miR-let-7b-CCNA2 competing endogenous RNA network associated with prognosis of lung adenocarcinoma.

Authors:  Yusheng Huang; Limei Zhong; Kechao Nie; Lijuan Li; Shaohua Song; Fengbin Liu; Peiwu Li; Donglin Cao; Yufeng Liu
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

6.  Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer.

Authors:  Xiao-Ling Ling; Tao Zhang; Xiao-Ming Hou; Da Zhao
Journal:  Onco Targets Ther       Date:  2015-06-30       Impact factor: 4.147

7.  Multi-slice computed tomography characteristics of solitary pulmonary ground-glass nodules: Differences between malignant and benign.

Authors:  Haiyang Hu; Qingguo Wang; Huamei Tang; Liwen Xiong; Qiang Lin
Journal:  Thorac Cancer       Date:  2015-06-12       Impact factor: 3.500

8.  Myoferlin expression in non-small cell lung cancer: Prognostic role and correlation with VEGFR-2 expression.

Authors:  Dae Hyun Song; Gyung Hyuck Ko; Jeong Hee Lee; Jong Sil Lee; Gyeong-Won Lee; Hyeon Cheol Kim; Jung Wook Yang; Rok Won Heo; Gu Seob Roh; Sun-Young Han; Dong Chul Kim
Journal:  Oncol Lett       Date:  2015-12-02       Impact factor: 2.967

9.  Definitive radiotherapy with or without chemotherapy for clinical stage T4N0-1 non-small cell lung cancer.

Authors:  Yeon Joo Kim; Si Yeol Song; Seong-Yun Jeong; Sang We Kim; Jung-Shin Lee; Su Ssan Kim; Wonsik Choi; Eun Kyung Choi
Journal:  Radiat Oncol J       Date:  2015-12-30

10.  Long non‑coding RNA SNHG3 promotes the development of non‑small cell lung cancer via the miR‑1343‑3p/NFIX pathway.

Authors:  Lijun Zhao; Xue Song; Yesong Guo; Naixin Ding; Tingting Wang; Lei Huang
Journal:  Int J Mol Med       Date:  2021-06-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.